Gisele Dion - 01 Sep 2022 Form 3 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Milton H. Werner, Attorney-In-Fact
Issuer symbol
IKT
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
3
Filing time
06 Sep 2022, 17:06:32 UTC
Previous filing
03 Jun 2022
Next filing
16 Jun 2023

No securities are beneficially owned.

Remarks:

Remarks: Exhibit List: Exhibit 24 - Power of Attorney